Corpus Intelligence IC Memo — ASPEN HILLS HEALTHCARE CENTER 2026-04-26 05:26 UTC
IC Memo — ASPEN HILLS HEALTHCARE CENTER
Investment Committee Memorandum | NJ | 30 beds | Grade D | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ASPEN HILLS HEALTHCARE CENTER

CCN 314023 | BURLINGTON, NJ | 30 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ASPEN HILLS HEALTHCARE CENTER is a 30-bed community hospital in BURLINGTON, NJ with $26.2M in net patient revenue and a -12.7% operating margin. The hospital serves a payer mix of 18.5% Medicare, 0.0% Medicaid, and 81.5% commercial.

Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.7% to -5.4% (+736bps).

Net Revenue HCRIS$26.2M
Current EBITDA COMPUTED$-3.3M
Operating Margin COMPUTED-12.7%
Occupancy HCRIS75.0%
Revenue / Bed COMPUTED$875K
Net-to-Gross HCRIS93.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

95
NJ Hospitals
-3.9%
State Median Margin
10
Comparable Hospitals

NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of -12.7% places it below the state median. Among 10 size-comparable peers (15-60 beds), the median margin is -3.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (15-60), prioritizing same-state peers. 10 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ASPEN HILLS HEALTHCARE CENTER (Target)NJ30$26.2M-12.7%
RAMAPO RIDGE PSYCHIATRICNJ58$78.4M-34.4%
ENCOMPASS HEALTH REHABILITATIONJ60$28.9M18.0%
ENCOMPASS HEALTH REHABILITATIONJ41$25.7M21.2%
ST. LAWRENCE REHABILITATION CENJ60$24.9M-27.1%
ATLANTIC REHABILITATION INSTITNJ38$23.2M22.9%
SSH - ATLANTIC CITYNJ30$21.0M11.4%
ACHS CENTRAL JERSEYNJ50$20.6M-5.9%
CORNERSTONE BEHAVIORAL HEALTH NJ44$18.2M-3.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$551K+210bp18mo
Cost to Collect4.5%2.5%$525K+200bp12mo
Denial Rate Reduction12.0%6.5%$519K+198bp12mo
A/R Days Reduction5200.0%3800.0%$319K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$551K
Cost to Collect
$525K
Denial Rate Reduction
$519K
A/R Days Reduction
$319K
Clean Claim Rate
$17K
Total EBITDA Uplift$1.9M
Current EBITDA$-3.3M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$-1.4M
Current Margin-12.7%
Pro Forma Margin-5.4%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.1M$-2.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.1M$-4.7M0.00x-100.0%
Bull Case9.0x11.0x$-4.6M$18K0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.6M$-1.3M0.00x-100.0%
Bear Case11.0x10.0x$-5.7M$-10.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.7M$-13.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 10 hospitals with 15-60 beds
  • Same-state prioritization (n=11)
  • Comp margins: P25=-25.7% / P50=-3.8% / P75=18.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.